FINWIRES · TerminalLIVE
FINWIRES

Foyou Pharma Gets Registration Certificate for Clopidogrel Bisulfate and Aspirin Tablets

By

Beijing Foyou Pharma (SHA:601089) obtained a drug registration certificate from China's National Medical Products Administration for its clopidogrel bisulfate and aspirin tablets, according to a Shanghai bourse filing on Friday.

The drug was developed by Sanofi for the secondary prevention of atherothrombotic events.

Related Articles